Gian Luca Araldi

Avanti Biosciences, Inc.

$5,214,480

Attributed

$6,728,206

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY2017–24

$2M$1.5M$1M$500K$0

'17

'18

'19

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$6,728,206 · 5

By mechanism

SB1$3,350,753 · 1

R44$2,279,783 · 1

R43$1,097,670 · 3

Top collaborators

Most similar at Avanti Biosciences, Inc.

Same institution · by research overlap

Richard S Bruno$174,618

Others in their field

Other Emerging Leaders on “Alzheimer&Apos”

Lance Allen Johnson · University Of Kentucky$7,508,882
Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
Jessica Brooke Langbaum · Banner Health$6,050,741
Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362

Research focus

Alzheimer&AposPharmaceutical PreparationsCollaborationsLeadBiological SciencesIn VitroBrainCatechinIn VivoS DiseaseDoseToxic EffectMediatingPropertyDisease ProgressionSafety StudyPhosphotransferasesBiological AvailabilityNeurofibrillary Tangle FormationNeuronsDrug IndustryPathogenesisDepositionNeuronal Dysfunction